Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles - Wu, Canhao; Xu, Qin; Wang, Huiyuan; Tu, Bin; Zeng, Jiaxin; Zhao, Pengfei; Shi, Mingjie; Qiu, Hong; Huang, Yongzhuo (Acta pharmaceutica Sinica. B, 2022)
Keywords: ACE2; COVID-19; Extracellular vesicles; Intranasal administration; Neutralization; Pseudovirus; SARS-CoV-2; Short Communication; Spike protein; EVs; SDS; Spike protein; Extracellular vesicles; Intranasal administration; PAGE; WB; RIPA; COVID-19; ACE2; BSA; SARS-CoV-2; FBS; Pseudovirus; NTA; RLU; S protein; TEM; Neutralization; FBS, fetal bovine serum; S protein, spike protein; WB, western blot; SDS, sodium dodecyl sulfate; NTA, nanoparticle tracking analysis; RLU, relative luminescence units; PAGE, polyacrylamide gel electrophoresis; BSA, bovine albumin; TEM, transmission electron microscope; ACE2, angiotensin-converting enzyme 2; RIPA, radio immunoprecipitation assay; EVs, extracellular vesicles